A clinical trial of levamisole in primary biliary cirrhosis
| Autor: | S. Hishon, P. J. Ciclitira, G. Tobin |
|---|---|
| Rok vydání: | 1982 |
| Předmět: |
Clinical Trials as Topic
medicine.medical_specialty Liver Cirrhosis Biliary business.industry MEDLINE Pilot Projects General Medicine Disease Levamisole medicine.disease Gastroenterology Clinical trial Primary biliary cirrhosis Immune system Afferent Internal medicine medicine Humans Liver function business Research Article medicine.drug |
| Zdroj: | Postgraduate Medical Journal. 58:701-703 |
| ISSN: | 1469-0756 0032-5473 |
| DOI: | 10.1136/pgmj.58.685.701 |
| Popis: | Summary A small pilot study of levamisole in primary biliary cirrhosis failed to demonstrate any improvement in liver function and immunological abnormalities even in ‘early’ cases. This may be due to the fact that the defect in the immune system lies in its afferent arm. At present, levamisole, which is potentially toxic, cannot be recommended in conventional doses for the treatment of this disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|